July 9 (Reuters) - BELLUS Health Inc BLU.TO :
* BELLUS HEALTH INITIATES PHASE 1 CLINICAL STUDY FOR ITS CHRONIC COUGH DRUG CANDIDATE, BLU-5937
* BELLUS HEALTH INC - STUDY RESULTS PHASE 1 CLINICAL STUDY FOR BLU-5937EXPECTED IN Q4 OF 2018
* BELLUS HEALTH INC - PHASE 2 PROOF-OF-CONCEPT STUDY FOR BLU-5937 IS EXPECTED TO BE INITIATED IN 2019